174 related articles for article (PubMed ID: 23514643)
1. Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.
Gundogan FC; Tas A; Altun S; Oz O; Erdem U; Sobaci G
Indian J Ophthalmol; 2013 Mar; 61(3):100-3. PubMed ID: 23514643
[TBL] [Abstract][Full Text] [Related]
2. Color vision testing versus pattern visual evoked potentials and optical coherence tomography parameters in subclinical optic nerve involvement in multiple sclerosis.
Yuksel B; Dogan B; Koctekin B; Atis N; Erdal A; Kurtulus F; Erol MK; Gomceli YB
J Clin Neurosci; 2019 Mar; 61():48-53. PubMed ID: 30455132
[TBL] [Abstract][Full Text] [Related]
3. Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis.
Sobaci G; Demirkaya S; Gundogan FC; Mutlu FM
J Neuroophthalmol; 2009 Sep; 29(3):197-202. PubMed ID: 19726941
[TBL] [Abstract][Full Text] [Related]
4. Visual evoked potentials during hyperthermia.
Saul RF; Hayat G; Selhorst JB
J Neuroophthalmol; 1995 Jun; 15(2):70-8. PubMed ID: 7550932
[TBL] [Abstract][Full Text] [Related]
5. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.
Longbrake EE; Lancia S; Tutlam N; Trinkaus K; Naismith RT
Mult Scler Relat Disord; 2016 Nov; 10():198-203. PubMed ID: 27919490
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
Esen E; Sizmaz S; Balal M; Yar K; Demirkiran M; Unal I; Demircan N
Curr Eye Res; 2016 Oct; 41(10):1353-1358. PubMed ID: 26882356
[TBL] [Abstract][Full Text] [Related]
7. Subclinical optic neuropathy in multiple sclerosis. A neuro-ophthalmological investigation by means of visually evoked response, Farnworth-Munsell 100 Hue test and Ishihara test and their diagnostic value.
Engell T; Trojaborg W; Raun NE
Acta Ophthalmol (Copenh); 1987 Dec; 65(6):735-40. PubMed ID: 3434241
[TBL] [Abstract][Full Text] [Related]
8. Analysis of multiple sclerosis patients with electrophysiological and structural tests.
Hamurcu M; Orhan G; Sarıcaoğlu MS; Mungan S; Duru Z
Int Ophthalmol; 2017 Jun; 37(3):649-653. PubMed ID: 27538913
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of retinal nerve fibre layer thickness and visual evoked potentials in optic neuritis associated with multiple sclerosis.
Chatziralli IP; Moschos MM; Brouzas D; Kopsidas K; Ladas ID
Clin Exp Optom; 2012 Mar; 95(2):223-8. PubMed ID: 22329676
[TBL] [Abstract][Full Text] [Related]
10. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?--A structural and functional evaluation.
Gundogan FC; Demirkaya S; Sobaci G
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5773-81. PubMed ID: 18055831
[TBL] [Abstract][Full Text] [Related]
11. Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
Taş A; Cakir Gundogan F; Akgun H; Erdem U; Sobaci G
Med Glas (Zenica); 2013 Feb; 10(1):99-105. PubMed ID: 23348170
[TBL] [Abstract][Full Text] [Related]
12. Correlation between morphological and functional retinal impairment in multiple sclerosis patients.
Parisi V; Manni G; Spadaro M; Colacino G; Restuccia R; Marchi S; Bucci MG; Pierelli F
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2520-7. PubMed ID: 10509645
[TBL] [Abstract][Full Text] [Related]
13. MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis.
Davies MB; Williams R; Haq N; Pelosi L; Hawkins CP
Neuroradiology; 1998 Dec; 40(12):765-70. PubMed ID: 9877128
[TBL] [Abstract][Full Text] [Related]
14. Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.
Laron M; Cheng H; Zhang B; Schiffman JS; Tang RA; Frishman LJ
Mult Scler; 2009 Dec; 15(12):1431-41. PubMed ID: 19995841
[TBL] [Abstract][Full Text] [Related]
15. The value of tests evaluating visual functions in detecting overt or subclinical optic neuritis in multiple sclerosis.
Öcek Ö; Gedizlioğlu M; Köşkderelioğlu A; Ortan PK; Yüksel B; Türe M; Gediz F
Mult Scler Relat Disord; 2018 Apr; 21():63-68. PubMed ID: 29471193
[No Abstract] [Full Text] [Related]
16. Functional-structural assessment of the optic pathways in patients with optic neuritis.
Schmidt MF; Pihl-Jensen G; Frederiksen JL
Doc Ophthalmol; 2020 Apr; 140(2):159-168. PubMed ID: 31624975
[TBL] [Abstract][Full Text] [Related]
17. Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.
Kolappan M; Henderson AP; Jenkins TM; Wheeler-Kingshott CA; Plant GT; Thompson AJ; Miller DH
J Neurol; 2009 Mar; 256(3):305-19. PubMed ID: 19296047
[TBL] [Abstract][Full Text] [Related]
18. Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
Laron M; Cheng H; Zhang B; Schiffman JS; Tang RA; Frishman LJ
Mult Scler; 2010 Apr; 16(4):412-26. PubMed ID: 20207786
[TBL] [Abstract][Full Text] [Related]
19. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
[TBL] [Abstract][Full Text] [Related]
20. Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
de Santiago L; Sánchez-Morla E; Blanco R; Miguel JM; Amo C; Ortiz Del Castillo M; López A; Boquete L
PLoS One; 2018; 13(4):e0194964. PubMed ID: 29677200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
